Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Authors
Keywords
E6 HPV, E7 HPV, HPV-16+, T-cell receptor, Cellular therapy, Cancer immunotherapy, Cervical cancer, Epithelial cancer, T-cell manufacturing
Journal
Journal of Translational Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-24
DOI
10.1186/s12967-018-1384-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
- (2017) David F. Stroncek et al. Journal of Translational Medicine
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
- (2017) Sanja Stevanović et al. SCIENCE
- T-cell receptor-engineered T cells for cancer treatment: current status and future directions
- (2017) Yu Ping et al. Protein & Cell
- Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells
- (2016) David F. Stroncek et al. CYTOTHERAPY
- Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy
- (2016) Ulrike Mock et al. CYTOTHERAPY
- A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies
- (2016) Tangying Lily Lu et al. Human Gene Therapy Methods
- Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
- (2015) L. M. Draper et al. CLINICAL CANCER RESEARCH
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
- (2012) Jianjian Jin et al. JOURNAL OF IMMUNOTHERAPY
- Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor
- (2012) Robert PT Somerville et al. Journal of Translational Medicine
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started